CANTON, Conn., Aug. 12, 2024 /PRNewswire/ -- Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its half year ended June 30, 2024. Financial highlights for the six months ended June 30, 2024 and the same period in 2023 include: Total revenue of $1,709,239 compared to $ 1,147,045, an increase of 49.01% Gross Margin of $1,330,965 compared to $871,510 an increase of 52.7% Operating profit of $172,093 compared to a loss of $229,345 representing an increase to profitability of $401,438 EBITDA (new metric to report) of $197,355 compared to an EBITDA loss of $204,691. The increase in profitability was primarily due to increased sales, efficiency improvements and reducing software, insurance ...